-
1
-
-
68249154875
-
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection
-
J.G. McHutchison, E.J. Lawitz, and M.L. Shiffman Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 2009 580 593
-
(2009)
N Engl J Med
, vol.361
, pp. 580-593
-
-
McHutchison, J.G.1
Lawitz, E.J.2
Shiffman, M.L.3
-
2
-
-
78049460599
-
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate
-
M.S. Sulkowski, M.L. Shiffman, and N.H. Afdhal Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate Gastroenterology 139 2010 1602 1611
-
(2010)
Gastroenterology
, vol.139
, pp. 1602-1611
-
-
Sulkowski, M.S.1
Shiffman, M.L.2
Afdhal, N.H.3
-
3
-
-
68249108956
-
Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C
-
D. Breilh, J. Foucher, and L. Castera Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C Aliment Pharmacol Ther 30 2009 487 494
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 487-494
-
-
Breilh, D.1
Foucher, J.2
Castera, L.3
-
4
-
-
0033806292
-
Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C
-
J.F. Jen, P. Glue, and S. Gupta Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C Ther Drug Monit 22 2000 555 565
-
(2000)
Ther Drug Monit
, vol.22
, pp. 555-565
-
-
Jen, J.F.1
Glue, P.2
Gupta, S.3
-
5
-
-
47649106599
-
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients
-
M. Maynard, P. Pradat, and M.C. Gagnieu Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients Antivir Ther 13 2008 607 611 (Pubitemid 352016724)
-
(2008)
Antiviral Therapy
, vol.13
, Issue.4
, pp. 607-611
-
-
Maynard, M.1
Pradat, P.2
Gagnieu, M.-C.3
Souvignet, C.4
Trepo, C.5
-
6
-
-
79952672318
-
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection
-
C. Pedersen, A. Alsio, and M. Lagging Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection J Viral Hepat 18 2011 245 251
-
(2011)
J Viral Hepat
, vol.18
, pp. 245-251
-
-
Pedersen, C.1
Alsio, A.2
Lagging, M.3
-
7
-
-
79955404664
-
Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients
-
L.G. van Vlerken, E.J. Huisman, and H. van Soest Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients J Viral Hep 2010 Nov 29 [Epub ahead of print]
-
(2010)
J Viral Hep
-
-
Van Vlerken, L.G.1
Huisman, E.J.2
Van Soest, H.3
-
8
-
-
0032949443
-
The clinical pharmacology of ribavirin
-
P. Glue The clinical pharmacology of ribavirin Semin Liver Dis 19 Suppl 1 1999 17 24 (Pubitemid 29220816)
-
(1999)
Seminars in Liver Disease
, vol.19
, Issue.1 SUPPL. 1
, pp. 17-24
-
-
Glue, P.1
|